Friday, February 23, 2024 |
FOLLOW US:

Rockville biotech continues buying spree with yet another acquisition

March 11, 2022

Rockville’s Emmes is sticking to its growth strategy for the past year with its fourth acquisition since a pandemic-era leadership change — and its first so far this year. The contract research organization, which conducts research and clinical trials for public and private sector customers, said Thursday it has purchased Plymouth, Massachusetts-based Casimir LLC, a fellow CRO focused on rare diseases, for an undisclosed amount. The 6-year-old Casimir brings to the table 31 U.S. employees and 25 clients, and experience in researching and testing more than 20 rare diseases.

Article Source: Washington Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.